Free Communications - Vaccines 4

5:00 PM • FC 12-01 • 14 years of follow-up on the long-term effectiveness and immunogenicity of the quadrivalent HPV vaccine in 4 Nordic countries > M. Mari NYGÅRD 5:12 PM • FC 12-02 • Bivalent HPV vaccine effectiveness against anal HPV positivity among female Dutch STI clinic visitors > P. Petra Woestenberg 5:24 PM • FC 12-03 • The HPV serology standardization initiative: aims and progress to date at the Frederick National Laboratory for Cancer Research > L. Ligia Pinto 5:36 PM • FC 12-04 • Effect of bivalent HPV immunisation on cytological and histological findings at second and subsequent screens - a longitudinal study > T. Timothy Palmer 5:48 PM • FC 12-05 • Impact of state legislation of human papillomavirus vaccination on vaccine uptake in the United States > N. Nadja Vielot 6:00 PM • FC 12-06 • Projected impact of vaccination on the risk of high-risk human papillomavirus infection and precancerous lesion > F. Federica Inturrisi 6:12 PM • FC 12-07 • HPV vaccine prescription and compliance in a cohort of women referred for colposcopy > C. Catarina Melo